Every year, Almac Group conducts a large-scale survey with industry professionals and prospects that aims to understand key trends in the outsourced pharmaceutical services industry – this year the survey was conducted against the unique backdrop of the COVID-19 pandemic.
Access the full document to find out more about:
- Exactly how R&D activity and clinical trials have been disrupted as a result of the pandemic.
- How the impact of COVID-19 has changed pharma, biotech & CROs needs now and post-COVID.
- How outsourced pharmaceutical providers can adapt, pivot and be eﬀective during and post-pandemic.